Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/30/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results
(NASDAQ: GLUE) Delayed: 13.38 -0.94 (6.56%)
Previous Close $14.32    52 Week High $ 
Open $14.29    52 Week Low $ 
Day High $14.30    P/E N/A 
Day Low $13.37    EPS $ 
Volume 884,650